Eton Pharmaceuticals (ETON) Change in Intangibles (2022 - 2024)

Eton Pharmaceuticals has disclosed Change in Intangibles across 3 years of filings, most recently posting $8.1 million for Q4 2024.

• Change in Intangibles for Q4 2024 came in at $8.1 million, up 947.61% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.1 million (up 207.19% YoY), and the FY2024 annual result was $10.0 million, up 1188.77% from the prior year.
• Change in Intangibles came in at $8.1 million for Q4 2024 at Eton Pharmaceuticals, up from $1.9 million in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of $8.1 million in Q4 2024 to a low of $750000.0 in Q1 2022.
• The 3-year median for Change in Intangibles is $1.9 million (2024), against an average of $2.7 million.
• Peak annual rise in Change in Intangibles reached 947.61% in 2024, while the deepest fall reached 947.61% in 2024.
• Eton Pharmaceuticals' Change in Intangibles stood at $2.1 million in 2022, then sank by 63.53% to $775000.0 in 2023, then jumped by 947.61% to $8.1 million in 2024.
• The last three Change in Intangibles figures came in at $8.1 million (Q4 2024), $1.9 million (Q1 2024), and $775000.0 (Q4 2023), per Business Quant data.